CAV1 and cardiac hypertrophy: For example, in one study, treating Cav-1 KO mice with the NOS inhibitor l-NAME in the first two months of life, resulted in a complete reversal of pathological pulmonary changes, heart hypertrophy and pulmonary arterial hypertension [77].